Navigation Links
World Radiopharmaceuticals Market to Reach USD 5.5bn in 2017, According to M&M Report Available at MarketPublishers.com
Date:8/19/2013

London, UK (PRWEB) August 19, 2013

Globally, the radiopharmaceuticals market is poised to reach USD 5.5 billion by end-2017, at a CAGR of about 8% during 2012-2017. Tc-99m diagnostic procedures are expected to increase to 20% in mature markets in the long run. Further, upcoming radioisotopes such as radium-223 chloride (alpharadin) and gallium-68 have big potential for clinical applications.

The therapy market is primarily driven by its oncologic applications, where radioisotopes are being preferred due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the upcoming future. The isotope has huge potential to grab market share from existing beta emitters and brachytherapy. North America is the dominant market for diagnostic radioisotopes with about 50% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Cardinal Health, Inc., GE Healthcare, Covidien, Plc, Lantheus Medical Imaging, Inc., Nordion, Inc., IBA Group, and Siemens Healthcare are the leading players in the radiopharmaceuticals market worldwide. The stable isotopes market is led by Cambridge Isotope Laboratories (CIL) and Isotec (Sigma Aldrich).

Comprehensive research study “Nuclear Medicine/Radiopharmaceuticals (SPECT/PET Radioisotopes (Technetium, F-18)), (Beta/Alpha radiation therapy (I131, Y-90)), (Applications (Cancer/Oncology, Cardiac)) & Stable Isotopes (Deuterium, C-13) Market - Global Trends & Forecast to 2017” elaborated by MarketsandMarkets (M&M) has been recently publi
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
2. Measles Deaths Falling Worldwide
3. Surprising results for use of dialysis for kidney failure in developing world
4. Blond Genes May Vary Around the World
5. Infection Causes 1 in 6 Cancers Worldwide: Study
6. New initiative aims to increase mobility for disabled children worldwide
7. World Health Assembly endorses new plan to increase global access to vaccines
8. People Who Lived Near World Trade Center Report More Lung Disease
9. After 25 years, World No Tobacco Day is making an impact
10. Brave New World of Genetics Requires Safeguards, Experts Say
11. UICC World Cancer Congress -- Aug. 27-30, 2012 -- Montreal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2015)... 28, 2015 CrossFit Attollo is a CrossFit ... offering a special discount to new members. Now through ... a three month contract will receive their fourth month half ... cost members $440. The three month contract is only ... then the fourth month comes in at only $55. The ...
(Date:2/28/2015)... 28, 2015 Gerald “Solutionman” Haman surveyed ... or barriers to innovative thinking. “The #1 block ... lack of tools,” reports Haman, who created the Thinkubator ... of people felt that they did not have enough ... and resources to stimulate innovation. , Solutionman’s monthly “Accelerating ...
(Date:2/28/2015)... 2015 Mew and Company, a Vancouver ... now provide business consulting services in addition to a ... planning and succession planning. Company finances are a complicated ... On top of this, complex Canadian tax laws can ... As a result, Mew and Company works to advise ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The ... its annual awards at the International Symposium on Malignant ... be held at the Hyatt Regency Bethesda in Bethesda, ... their dedicated work and commitment to the mission to ... Year Award will be presented to Miriam Ratner. Miriam ...
(Date:2/28/2015)... 28, 2015 A case management conference ... that have been filed by law firms including Bernstein ... in March, the Firm notes. , According to ... in the federal litigation will meet on March 13, ... prescription therapy treatments designed to raise levels of the ...
Breaking Medicine News(10 mins):Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 2Health News:New Survey Reveals “Lack of Time” Is the Number #1 Barrier to Innovative Thinking 3Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4
... Boniva, Zometa does not apply to obese women, however , ... drugs used to prevent and treat osteoporosis might reduce the ... study, which included 6,000 Wisconsin women aged 20 to 69, ... Boniva and Zometa for more than two years were 40 ...
... ... ... , ... , , , ...
... ... a new partnership with leading SolidWorks and Agile PLM reseller GoEngineer to distribute DesignState ... "best-in-class" tools to manage engineering data and collaborate across the enterprise with Oracle,s ... ...
... ... of a new resource that may help put some of your questions to bed. BestFoodFacts.org, ... the country to weigh in on what’s true, plausible, unknown, misguided or just plain false. ... (PRWEB) March 5, 2010 ...
... ... that society’s obligation and moral responsibility to remedy the tragic legacy of decades of ... follow? , ... March 5, 2010 -- The Mesothelioma Applied Research Foundation today publicly praised the United ...
... 39th Annual Meeting of the American Association for ... Convention Center in Washington, DC, lead researcher M. ... poster of a study titled "Epithelial-to-Endothelial Transition: An ... and a team of researchers have reported that ...
Cached Medicine News:Health News:Certain Bone Drugs May Lower Breast Cancer Risk 2Health News:Christiana Care Health System Wins National Award for Innovation 2Health News:Christiana Care Health System Wins National Award for Innovation 3Health News:Enterprise PDM Integration has Never Been Easier; Zero Wait-State Announces Leading SolidWorks Reseller GoEngineer as Master Distributor for DesignState 2Health News:Enterprise PDM Integration has Never Been Easier; Zero Wait-State Announces Leading SolidWorks Reseller GoEngineer as Master Distributor for DesignState 3Health News:BestFoodFacts.org -- Food, Fiber and Fuel Questions Answered 2Health News:U.K.: Justice for Asbestos Disease Victims Requires Mesothelioma Research Funding 2Health News:U.K.: Justice for Asbestos Disease Victims Requires Mesothelioma Research Funding 3
(Date:2/27/2015)... 2015   Synageva BioPharma Corp. (Synageva) ... developing therapeutic products for rare diseases, joins the ... Organisation for Rare Diseases™ (EURORDIS™), The Global Genes ... Rare Disease Day. On the last ... and other participants conduct special events to raise ...
(Date:2/27/2015)... Israel , February 27, 2015 /PRNewswire/ ... baut sein bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz ... aus -     ... Technologies, die ein neuartiges Herzüberwachungssystem für Patienten ... heute bekannt, dass sie ein Finanzierungsvorhaben über ...
(Date:2/26/2015)... SANTA CLARA, Calif. , Feb. 27, 2015  Finesse ... Finesse Solutions announced the expansion of ... The opening is planned for mid-March and access for ... access from the A-563, and located adjacent to the ... occupied by the Finesse automation engineering team and allow Finesse ...
Breaking Medicine Technology:Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2New Finesse Office in United Kingdom 2
... EMERYVILLE, Calif., Oct. 26, 2011 Bionovo, Inc. (Nasdaq: ... the discovery and development of safe and effective treatments ... has started to the Phase 3 pivotal clinical trial ... Menerba™ (MF101) among a cohort of postmenopausal women for ...
... Inc. (Nasdaq: NBIX ) announced today that the ... the Nasdaq market closes on Monday,  October 31, 2011.  Neurocrine ... discuss its financial results and provide a Company update Monday ... p.m. Pacific Time). Participants can access the live ...
Cached Medicine Technology:Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes 2Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes 3Bionovo Initiates Menerba (MF101) Phase 3 Clinical Trial for Menopausal Hot Flashes 4
BD Beaver Cataract blade, 30.0 mm long x 2.2 mm wide, designed for ICCE and ECCE procedures, designed for ICCE and ECCE, sterile....
BD Beaver Chondroplastic blade, sharp on two sides, curved, sterile...
BD Beaver Meniscus blade, 7 mm flat (4/bx, 1 bx/ca), specially designed maximum leverage and visibility, cutting edge: 7 mm, sterile....
... accurate testing of large oculomotor ... Fits all standard trial frames. ... of thin optical quality acrylic ... includes a display box. Available ...
Medicine Products: